UC Irvine School of Medicine's Revolutionary iPad Program to Utilize E-Textbooks from Elsevier

First-year Med Students Will Access Four Key Titles, Including Netter: Atlas of Human Anatomy, From Their UCI-furnished iPads

PHILADELPHIA, August 26, 2010 - Elsevier, a world-leading publisher of scientific, technical
and medical information products and services, announced today it will
provide four key electronic textbook titles for UC Irvine School of
Medicine's new program that gives Apple iPads to its first-year medical
students.

Elsevier will provide UCI's incoming medical students with
access to Netter: Atlas of Human Anatomy, Gartner: Color Textbook of
Histology, Costanzo Physiology and Nussbaum: Thompson & Thompson Genetics in
Medicine - all through their new iPads.

"We believe a digitally based curriculum is the future of
medical education," said Dr. Ralph V. Clayman, dean of the UCI School of
Medicine. "Our commitment to provide these students with the best technology
platform and content available is shared by Elsevier, which has responded
quickly and positively to our request for high-quality e-textbooks accessible
through the iPad."

UCI School of Medicine students and faculty will use their
iPads to access Student Consult, (www.studentconsult.com/) Elsevier's
online portal where students can access full textbooks plus additional
interactive content. Student Consult is where UCI med students will find the
four e-textbooks selected for the first term courses. Elsevier will work
closely with UCI to monitor the use of the content and the iPads.

"UCI is setting the bar high for how medical schools students
and professors should be interacting with medical textbooks," said Randy
Charles, Managing Director for Elsevier's Global Clinical Reference Group.
"We fully support UCI's progressive move and are working hard to make more of
our respected medical content available through mobile devices like the iPad
and iPhone."

UCI anticipates it will add further Elsevier texts as the school year
progresses.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is owned jointly by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Tom Reller
    Vice President, Global Corporate Relations
    +1-215-239-3508
    T.Reller@Elsevier.com

Media Contact: Tom Reller, Vice President, Global Corporate Relations, +1-215-239-3508, T.Reller at Elsevier.com